Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 55.74
+0.20 (0.36%)
At close: Sep 16, 2026
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 25.93 billion as of September 16, 2026. Its market cap has decreased by -23.06% in one year.
Market Cap
25.93B
Enterprise Value
25.55B
Revenue
968.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
55.74
ChartMarket Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 25.93B, an increase of 57.71%. That is a compound annual growth rate of 10.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 25.93B | -2.39% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Tongrentang | 31.98B |
| Humanwell Healthcare (Group) | 30.02B |
| Dong-E-E-Jiao | 29.36B |
| Changchun High-Tech Industry (Group) | 28.80B |
| Shijiazhuang Yiling Pharmaceutical | 25.39B |
| Apeloa Pharmaceutical Co.,Ltd | 25.18B |
| Zhejiang Huahai Pharmaceutical | 24.16B |
| Hubei Jumpcan Pharmaceutical | 23.38B |